Drug class · Oncology & immunology
Kinase inhibitors
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| sirolimus | Sirolimus .5 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4449 |
| sorafenib | Sorafenib tosylate 200 mg/1 | Tablet, Film coatedOral | Dr.Reddys Laboratories Inc | 43598-458 |
| sorafenib | Sorafenib 200 mg/1 | Tablet, Film coatedOral | Upsher-Smith Laboratories, LLC | 24979-715 |
| sorafenib | Sorafenib 200 mg/1 | Tablet, Film coatedOral | Golden State Medical Supply, Inc. | 51407-760 |
| sorafenib | Sorafenib 200 mg/1 | Tablet, Film coatedOral | Yabao Pharmaceutical Co., Ltd. Beijing | 51990-201 |
| tofacitinib | Tofacitinib citrate 10 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1967 |
| tofacitinib | Tofacitinib citrate 22 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Lifesciences Limited | 70771-1628 |
| tofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Lifesciences Limited | 70771-1627 |
| tofacitinib | Tofacitinib citrate 5 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1243 |
| tofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1353 |
| tofacitinib | Tofacitinib citrate 5 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1821 |
| tofacitinib | Tofacitinib citrate 10 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1589 |
| tofacitinib | Tofacitinib citrate 22 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1727 |
| tofacitinib solutiontofacitinib | Tofacitinib citrate 1 mg/mL | SolutionOral | Hikma Pharmaceuticals USA Inc. | 0054-0821 |